Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, has announced that the company will be starting a potentially lucrative relationship with a major player in cold chain development.
"This new collaboration will focus on our passive cooling technologies. Reflect will be developing customer-specific protocols and installing technologies along with developing new techniques that will bring significant improvement to customers' existing products. The Cold Chain Pharmaceuticals industry has been growing in the last few years becoming an $8 billion industry within just the US and worldwide in excess of $400 billion annually. As we have already done with our blast freezing and cryopreservation products, I see a quantum step forward in cold chain management solutions originating from Reflect Scientific," said Dr. Boyd Bowdish, Principal Scientist at Reflect Scientific.